Hints and tips:
...Eli Lilly, which had withdrawn from the previous voluntary scheme, welcomed its successor as “an important compromise”....
...The US Food and Drug Administration delayed an approval decision on Eli Lilly’s breakthrough Alzheimer’s disease drug, which was expected to be approved this month....
...Eli Lilly said it was considering other locations in Europe because of concerns about a “stifling commercial environment” in the UK....
...Need to know: UK and Europe economy The UK borrowed much less than expected in December, boosting Chancellor Jeremy Hunt’s plans to cut taxes ahead of the forthcoming general election....
...Novo Nordisk has followed Eli Lilly in slashing prices for some of its products by 75 per cent....
...Wegovy, Novo Nordisk’s obesity drug, has for the first time a direct competitor: Eli Lilly’s injectable tirzepatide....
...[MUSIC PLAYING] UK Chancellor Jeremy Hunt has raised the prospect of cutting interest rates in 2024....
...Jeremy Hunt will on Thursday answer questions from MPs after delivering his Autumn Statement, which is a fiscal statement rather than an annual Budget....
...Jeremy Kamil, a virologist studying Sars-Cov-2 evolution at Louisiana State University Health Shreveport, describes his shock when its genome was released....
...Jeremy Hughes, the chief executive of the Alzheimer’s Society, a charity, welcomed the new centre and said it “fortifies the UK as a global leader in dementia research”....
...When you want to buy drug stocks, before had to buy Abbott Labs, Merck and Eli Lilly. You had to buy each and decide in each name how aggressive you wanted to be....
...US investment bank JPMorgan will help set up the fund, with GlaxoSmithKline, Johnson & Johnson, Pfizer, Eli Lilly and Biogen Idec among the companies committing money alongside the UK government....
...She’s asking a follow-up to Mr Romney about the long-term unemployed who need a job much sooner than Jeremy Epstein....
...Boehringer has an option to develop one additional Lilly molecule....
...Other companies with more than 20 per cent of their pension portfolios invested in “level 3” assets include GE, Citi, Verizon and Eli Lilly, according to Credit Suisse....
...Healthcare was the only sector in positive territory for much of the day but it too gave up gains at the close in spite of upbeat results news from Eli Lilly and Bristol-Myers Squibb....
...Eli Lilly said profit had more than doubled but it still missed analysts’ estimates because of a charge for dropping its inhaled insulin product. Lilly shares slipped 4.7 per cent to $49.60....
...The news hit competitors Eli Lilly and Merck , which fell 2.2 per cent to $51.39 and 2.7 per cent to $39.22 respectively, knocking 0.8 per cent off the healthcare sector....
...And to back up this year’s 17-day show, Lilly has produced a substantial catalogue and is having a symposium to talk through many of the issues involved....
...Jeremy Mean, senior policy manager at the agency, said: “This complaint raises important issues not only about the importance of accurate information on safe use of medicines but about the relationship between...
International Edition